DR319-DP

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameDR319-DP
Drug Alias NameDR319-DP
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Trop-2Anti-NECTIN4DNA topoisomerase I inhibitors +[4] 
TargetsTumor-associated calcium signal transducer 2Nectin-4DNA topoisomerase I +[4] 
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Doer Biologics Corp
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Doer Biologics Corp
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A